Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function

Inclusion Criteria: * Men or women aged between 50 and 75 years (inclusive) * BMI ≥18.5 kg/m2 and ≤32 kg/m2 at the Screening Visit. * Group A: Patients with severe renal impairment renal impairment (creatinine clearance (ClCr) ≤29 mL/min) * Group B: Healthy subjects with normal kidney function (creatinine clearance (ClCr) ≥90 mL/min, inclusive) * Group C: Patients with moderate renal impairment ((creatinine clearance between 30 - 59 mL/min, inclusive) * Group D: Patients with mild renal impairment (Creatinine clearance between 60 - 89 mL/min, inclusive) Exclusion Criteria: •The subject has taken disallowed medication \<1 week prior to the first dose of IMP or \<5 half-lives prior to the first dose of IMP for any disallowed medication taken, whichever is longer) Other protocol defined inclusion and exclusion criteria do apply